231 related articles for article (PubMed ID: 31836014)
1. FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake.
Li L; Zhao H; Chen B; Fan Z; Li N; Yue J; Ye Q
J Transl Med; 2019 Dec; 17(1):418. PubMed ID: 31836014
[TBL] [Abstract][Full Text] [Related]
2. HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter.
Xu X; Shi X; Chen Y; Zhou T; Wang J; Xu X; Chen L; Hu L; Shen X
Metabolism; 2018 Aug; 85():126-138. PubMed ID: 29577938
[TBL] [Abstract][Full Text] [Related]
3. Regulation of carbohydrate metabolism by the farnesoid X receptor.
Stayrook KR; Bramlett KS; Savkur RS; Ficorilli J; Cook T; Christe ME; Michael LF; Burris TP
Endocrinology; 2005 Mar; 146(3):984-91. PubMed ID: 15564327
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
[TBL] [Abstract][Full Text] [Related]
5. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
6. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
Zhang HM; Wang X; Wu ZH; Liu HL; Chen W; Zhang ZZ; Chen D; Zeng TS
Mol Med Rep; 2016 Mar; 13(3):2135-42. PubMed ID: 26782298
[TBL] [Abstract][Full Text] [Related]
8. Bile acid receptor agonist GW4064 regulates PPARγ coactivator-1α expression through estrogen receptor-related receptor α.
Dwivedi SK; Singh N; Kumari R; Mishra JS; Tripathi S; Banerjee P; Shah P; Kukshal V; Tyagi AM; Gaikwad AN; Chaturvedi RK; Mishra DP; Trivedi AK; Sanyal S; Chattopadhyay N; Ramachandran R; Siddiqi MI; Bandyopadhyay A; Arora A; Lundåsen T; Anakk SP; Moore DD; Sanyal S
Mol Endocrinol; 2011 Jun; 25(6):922-32. PubMed ID: 21493670
[TBL] [Abstract][Full Text] [Related]
9. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
10. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.
Ma Y; Huang Y; Yan L; Gao M; Liu D
Pharm Res; 2013 May; 30(5):1447-57. PubMed ID: 23371517
[TBL] [Abstract][Full Text] [Related]
11. Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist.
Zhao T; Wang J; He A; Wang S; Chen Y; Lu J; Lv J; Li S; Wang J; Qian M; Li H; Shen X
Metabolism; 2021 Jun; 119():154771. PubMed ID: 33831422
[TBL] [Abstract][Full Text] [Related]
12. Dual Regulation of Gluconeogenesis by Insulin and Glucose in the Proximal Tubules of the Kidney.
Sasaki M; Sasako T; Kubota N; Sakurai Y; Takamoto I; Kubota T; Inagi R; Seki G; Goto M; Ueki K; Nangaku M; Jomori T; Kadowaki T
Diabetes; 2017 Sep; 66(9):2339-2350. PubMed ID: 28630133
[TBL] [Abstract][Full Text] [Related]
13. Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice.
Aljaylani A; Fluitt M; Piselli A; Shepard BD; Tiwari S; Ecelbarger CM
Cell Physiol Biochem; 2020 Jul; 54(4):682-695. PubMed ID: 32678535
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
15. Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α.
Wang S; Yuan X; Lu D; Guo L; Wu B
Biochem Pharmacol; 2017 Dec; 145():202-209. PubMed ID: 28912067
[TBL] [Abstract][Full Text] [Related]
16. Effect of forkhead box O1 in renal tubular epithelial cells on endotoxin-induced acute kidney injury.
Zhang M; Dong W; Li Z; Xiao Z; Xie Z; Ye Z; Liu S; Li R; Chen Y; Zhang L; Wang M; Liang H; Baihetiyaer R; Apaer R; Dong Z; Liang X
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F262-F272. PubMed ID: 33356954
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
18. MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice.
Wu Z; Jiao P; Huang X; Feng B; Feng Y; Yang S; Hwang P; Du J; Nie Y; Xiao G; Xu H
J Clin Invest; 2010 Nov; 120(11):3901-11. PubMed ID: 20921625
[TBL] [Abstract][Full Text] [Related]
19. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
